Main Menu

NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Novo Nordisk A/S (NYSE: NVO)

 
NVO Technical Analysis
5
As on 24th Nov 2025 NVO SHARE Price closed @ 44.97 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 70.94 & Strong Sell for SHORT-TERM with Stoploss of 90.86 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

NVOSHARE Price

Open 43.42 Change Price %
High 45.22 1 Day -2.66 -5.58
Low 43.08 1 Week -4.19 -8.52
Close 44.97 1 Month -12.53 -21.79
Volume 73239509 1 Year -61.83 -57.89
52 Week High 111.69 | 52 Week Low 44.97
 
NYSE USA Most Active Stocks
FSR 0.02 0.00%
DDR 15.44 -4.46%
TWTR 53.70 0.66%
SWN 7.11 -0.56%
BACA-U 302.00 0.67%
ENLC 14.12 -0.21%
NVO 44.97 -5.58%
T 25.62 -1.20%
OSCR 16.49 22.33%
PLTR 162.25 4.78%
 
NYSE USA Top Gainers Stocks
CND-WT 0.05 400.00%
WEI 0.44 51.72%
QFTA 10.26 51.33%
MOTV 18.70 50.20%
CORR 0.03 50.00%
WE 0.50 42.86%
WE 0.50 42.86%
KUKE 1.39 39.00%
DMS 0.45 36.36%
BFLY-WS 0.04 33.33%
 
NYSE USA Top Losers Stocks
AJX 0.01 -99.67%
AJX 0.01 -99.67%
AJX 0.01 -99.67%
QFTA-WS 0.46 -95.33%
TWND-WS 0.48 -95.12%
CHAA-WS 0.53 -94.56%
PMVC-WS 0.58 -94.10%
PIAI-WS 0.58 -94.09%
PCPC-WS 1.50 -93.83%
FTEV-WS 0.60 -93.81%
 
 
NVO
Daily Charts		 NVO
Intraday Charts		 Whats New @
Bazaartrend		 NVO
Free Analysis
 
NVO Important Levels Intraday
RESISTANCE49.09
RESISTANCE47.77
RESISTANCE46.95
RESISTANCE46.14
SUPPORT43.80
SUPPORT42.99
SUPPORT42.17
SUPPORT40.85
 
NVO Forecast November 2025
Share
4th UP Forecast68.38
3rd UP Forecast60.87
2nd UP Forecast56.23
1st UP Forecast51.59
1st DOWN Forecast38.35
2nd DOWN Forecast33.71
3rd DOWN Forecast29.07
4th DOWN Forecast21.56
 
NVO Weekly Forecast
4th UP Forecast53.20
3rd UP Forecast50.56
2nd UP Forecast48.93
1st UP Forecast47.30
1st DOWN Forecast42.64
2nd DOWN Forecast41.01
3rd DOWN Forecast39.38
4th DOWN Forecast36.74
 
NVO Forecast2025
4th UP Forecast178.74
3rd UP Forecast135.84
2nd UP Forecast109.32
1st UP Forecast82.8
1st DOWN Forecast7.14
2nd DOWN Forecast-19.38
3rd DOWN Forecast-45.9
4th DOWN Forecast-88.8
 
 
NVO Other Details
Segment EQ
Market Capital 247091216384.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
NVO Address
NVO
 
NVO Latest News
 
Your Comments and Response on Novo Nordisk A/S
 
NVO Business Profile
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabetic products, obesity, and other chronic diseases. The Biopharmaceuticals segment offers products in the areas of haemophilia, growth disorders, and hormone replacement therapy. The company collaboration agreements with Lund University to develop treatment for Parkinson's diseases; and bluebird bio, Inc. to develop genome editing treatments for children and adult patients. Novo Nordisk A/S also has a research collaboration with Lumen Bioscience, Inc. to explore strategies for delivering oral biologics for cardiometabolic disease. The company was founded in 1923 and is headquartered in Bagsvaerd, Denmark. Address: Novo Allé 1, Bagsvaerd, Denmark, 2880
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service